NEW YORK – Rakuten Medical, a cancer therapy developer, has escalated a trademark dispute by suing Illumina in US federal court. According to a complaint filed Wednesday in the US District Court for the District of Northern California, Rakuten Medical seeks a declaration that its Illuminox platform will not infringe Illumina’s trademarks. Filings submitted by Illumina to the US Patent and Trademark Office Trademark Trial and Appeal Board (TTAB) show that the sequencing firm has asked the agency to reject Rakuten Medical’s application for the Illuminox trademark.Rakuten Medical has also asked the court to award it attorneys’ fees associated with the suit.
Opposition (Illuminox v. Illumina)
Number: 91254560 Filing Date: 03/03/2020
Status: Pending Status Date: 03/10/2020
General Contact Number: 571-272-8500
Name: Rakuten Medical, Inc.
Name: Illumina, Inc.
Rakuten Medical: Our Journey toward Conquering Cancer, 5:30